Alister Cowan's most recent trade in Chemours Company was a trade of 7,182 Common Stock done . Disclosure was reported to the exchange on May 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Chemours Co | Alister Cowan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2026 | 7,182 | 43,881 (0%) | 0% | 0 | Common Stock | |
| Chemours Co | Alister Cowan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2025 | 14,096 | 35,830 (0%) | 0% | 0 | Common Stock | |
| Chemours Co | Alister Cowan | Director | Grant, award, or other acquisition of securities at price $ 19.26 per share. | 15 Nov 2024 | 10,200 | 21,582 (0%) | 0% | 19.3 | 196,471 | Common Stock |
| Chemours Co | Alister Cowan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2024 | 8,547 | 11,226 (0%) | 0% | 0 | Common Stock | |
| Chemours Co | Cowan Alister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 2,628 | 2,628 (0%) | 0% | 0 | Common Stock |